TECH - Bio-Techne Corporation
NASDAQ
->
Healthcare
->
Biotechnology
Minneapolis,
United States
Type: Equity
TECH price evolution
TECH
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $130.13 | $148.66 | ||
| Short term investments | $5.52 | |||
| Net receivables | $207.45 | $204.57 | ||
| Inventory | $180.84 | $186.08 | ||
| Total current assets | $590.64 | $591.48 | ||
| Long term investments | ||||
| Property, plant & equipment | $335.07 | $333.96 | ||
| Goodwill & intangible assets | $1530.69 | $1548.35 | ||
| Total noncurrent assets | $2140.11 | $2163.88 | ||
| Total investments | $5.52 | |||
| Total assets | $2730.75 | $2755.36 | ||
| Current liabilities | ||||
| Accounts payable | $31.51 | $29.83 | ||
| Deferred revenue | $28.43 | $24.52 | ||
| Short long term debt | $12.67 | $12.2 | ||
| Total current liabilities | $135.23 | $127.75 | ||
| Long term debt | $543.03 | $537.33 | ||
| Total noncurrent liabilities | $631.96 | $629.86 | ||
| Total debt | $555.7 | $549.53 | ||
| Total liabilities | $767.19 | $757.61 | ||
| Shareholders' equity | ||||
| Retained earnings | $1261.38 | $1327.57 | ||
| Other shareholder equity | -$63.66 | -$78.02 | ||
| Total shareholder equity | $1963.56 | $1997.75 | ||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Jul 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $180.57 | $172.57 | $199.09 | $146.63 |
| Short term investments | $23.74 | $74.46 | $32.46 | $124.27 |
| Net receivables | $218.47 | $194.55 | $145.38 | $122.53 |
| Inventory | $171.64 | $141.12 | $116.75 | $103.15 |
| Total current assets | $621.48 | $605.56 | $510.61 | $520.92 |
| Long term investments | ||||
| Property, plant & equipment | $324.53 | $288.8 | $207.91 | $248.29 |
| Goodwill & intangible assets | $1407.38 | $1353.62 | $1459.04 | $1244.85 |
| Total noncurrent assets | $2017.21 | $1689.25 | $1752.35 | $1506.67 |
| Total investments | $23.74 | $74.46 | $32.46 | $124.27 |
| Total assets | $2638.69 | $2294.8 | $2262.96 | $2027.59 |
| Current liabilities | ||||
| Accounts payable | $29.18 | $33.87 | $99.96 | $29.03 |
| Deferred revenue | $23.07 | $23.41 | $19 | $13.05 |
| Short long term debt | $11.2 | $24.43 | $24.1 | $22.04 |
| Total current liabilities | $128.51 | $176.02 | $152.28 | $106.67 |
| Long term debt | $443.77 | $301.54 | $328.83 | $411.49 |
| Total noncurrent liabilities | $543.67 | $417.78 | $539.44 | $539.73 |
| Total debt | $454.96 | $325.97 | $420.55 | $433.53 |
| Total liabilities | $672.18 | $593.79 | $691.72 | $646.4 |
| Shareholders' equity | ||||
| Retained earnings | $1309.46 | $1122.92 | $1085.46 | $1057.47 |
| Other shareholder equity | -$66.06 | -$75.2 | $1571.23 | -$97.2 |
| Total shareholder equity | $1966.52 | $1701.77 | $1562.97 | $1381.19 |
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Jul 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $931.03 | $738.69 | ||
| Cost of revenue | $298.18 | $255.5 | ||
| Gross Profit | $632.85 | $483.19 | ||
| Operating activities | ||||
| Research & development | $70.6 | $65.19 | ||
| Selling, general & administrative | $324.95 | $260.58 | ||
| Total operating expenses | $395.74 | $325.77 | ||
| Operating income | $237.3 | $157.42 | ||
| Income from continuing operations | ||||
| EBIT | $162.95 | $295.67 | ||
| Income tax expense | $8.59 | $47.18 | ||
| Interest expense | $13.95 | $19.2 | ||
| Net income | ||||
| Net income | $140.41 | $229.3 | ||
| Income (for common shares) | $140.41 | $229.3 | ||
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $27.46 | $50.99 | $75.48 | $70.22 |
| Operating activities | ||||
| Depreciation | $27.8 | $28.54 | $26.92 | $26.97 |
| Business acquisitions & disposals | -$3.28 | -$164.28 | -$232 | |
| Stock-based compensation | $12.75 | $10.09 | -$2.08 | $10.11 |
| Total cash flows from operations | $83.12 | $59.38 | $83.39 | $50.53 |
| Investing activities | ||||
| Capital expenditures | -$14.86 | -$13.59 | -$10.83 | -$11.75 |
| Investments | -$5.53 | $23.76 | $6.08 | $2.65 |
| Total cash flows from investing | -$23.67 | -$154.11 | -$4.76 | -$241.1 |
| Financing activities | ||||
| Dividends paid | -$12.56 | -$12.65 | -$12.6 | -$12.58 |
| Sale and purchase of stock | -$74.77 | $14.39 | $8.41 | $4.42 |
| Net borrowings | $7 | $90 | -$20 | $170 |
| Total cash flows from financing | -$81.4 | $71.51 | -$24.22 | $150.84 |
| Effect of exchange rate | $3.42 | -$8.69 | -$1.13 | $2.32 |
| Change in cash and equivalents | -$18.53 | -$31.91 | $53.29 | -$37.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 30 Jul 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $285.26 | $272.05 | $140.41 | $229.3 |
| Operating activities | ||||
| Depreciation | $107.24 | $101.07 | $87.75 | $82.74 |
| Business acquisitions & disposals | -$242.14 | -$225.91 | $1.91 | |
| Stock-based compensation | $39.23 | $42.18 | $48.98 | $32.37 |
| Total cash flows from operations | $254.39 | $325.27 | $352.16 | $205.22 |
| Investing activities | ||||
| Capital expenditures | -$38.24 | -$44.91 | -$44.3 | -$51.74 |
| Investments | $14.74 | -$51.94 | $26.69 | $76.93 |
| Total cash flows from investing | -$265.65 | -$96.85 | -$243.52 | $27.09 |
| Financing activities | ||||
| Dividends paid | -$50.28 | -$50.19 | -$49.62 | -$48.9 |
| Sale and purchase of stock | $10.25 | -$83.8 | $21.91 | $20.87 |
| Net borrowings | $94 | -$85.5 | -$15.5 | -$148.5 |
| Total cash flows from financing | $22.62 | -$242.85 | -$62.55 | -$183.8 |
| Effect of exchange rate | -$3.36 | -$12.09 | $6.37 | -$2.77 |
| Change in cash and equivalents | $8 | -$26.52 | $52.47 | $45.74 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.34 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |